| European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer J Bernier N Engl J Med 350, 1956-1952, 2004 | 681* | 2004 |
| Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 19732007 surveillance, epidemiology, and end results data CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, ... Cancer 118 (18), 4444-4451, 2012 | 352 | 2012 |
| Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 19732007 surveillance, epidemiology, and end results data CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, ... Cancer 118 (18), 4444-4451, 2012 | 352 | 2012 |
| Recurrent laryngeal nerve monitoring versus identification alone on postthyroidectomy true vocal fold palsy: a metaanalysis TS Higgins, R Gupta, AS Ketcham, RT Sataloff, JT Wadsworth, JT Sinacori The Laryngoscope 121 (5), 1009-1017, 2011 | 300 | 2011 |
| Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009 B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, ... Cancer 119 (14), 2602-2610, 2013 | 218 | 2013 |
| Midface reconstruction with the fibula free flap ND Futran, JT Wadsworth, D Villaret, DG Farwell Archives of Otolaryngology–Head & Neck Surgery 128 (2), 161-166, 2002 | 213 | 2002 |
| Serum protein profiles to identify head and neck cancer JT Wadsworth, KD Somers, LH Cazares, G Malik, BL Adam, BC Stack Jr, ... Clinical Cancer Research 10 (5), 1625-1632, 2004 | 158 | 2004 |
| Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results … NF Saba, M Goodman, K Ward, C Flowers, S Ramalingam, T Owonikoko, ... Oncology 81 (1), 12-20, 2011 | 157 | 2011 |
| Identification of patients with head and neck cancer using serum protein profiles JT Wadsworth, KD Somers, BC Stack Jr, L Cazares, G Malik, BL Adam, ... Archives of Otolaryngology–Head & Neck Surgery 130 (1), 98-104, 2004 | 149 | 2004 |
| Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial RC Smallridge, JA Copland, MS Brose, JT Wadsworth, Y Houvras, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), 2392-2400, 2013 | 123 | 2013 |
| Differential capture of serum proteins for expression profiling and biomarker discovery in preand posttreatment head and neck cancer samples GL Freed, LH Cazares, CE Fichandler, TW Fuller, CA Sawyer, BC Stack Jr, ... The Laryngoscope 118 (1), 61-68, 2008 | 93 | 2008 |
| Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth LA Marlow, LA Reynolds, AS Cleland, SJ Cooper, ML Gumz, S Kurakata, ... Cancer research 69 (4), 1536-1544, 2009 | 92 | 2009 |
| Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers RR Drake, LH Cazares, OJ Semmes, JT Wadsworth Expert review of molecular diagnostics 5 (1), 93-100, 2005 | 85 | 2005 |
| Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma JV de la Iglesia, RJC Slebos, L Martin-Gomez, X Wang, JK Teer, AC Tan, ... Clinical Cancer Research 26 (6), 1474-1485, 2020 | 81 | 2020 |
| Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy RS Prabhu, S Hanasoge, KR Magliocca, WA Hall, SA Chen, KA Higgins, ... Head & neck 37 (6), 777-782, 2015 | 80 | 2015 |
| Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target LA Marlow, J D'Innocenzi, Y Zhang, SD Rohl, SJ Cooper, T Sebo, C Grant, ... The Journal of Clinical Endocrinology & Metabolism 95 (12), 5338-5347, 2010 | 80 | 2010 |
| Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target LA Marlow, J D'Innocenzi, Y Zhang, SD Rohl, SJ Cooper, T Sebo, C Grant, ... The Journal of Clinical Endocrinology & Metabolism 95 (12), 5338-5347, 2010 | 80 | 2010 |
| HER3 targeting sensitizes HNSCC to cetuximab by reducing HER3 activity and HER2/HER3 dimerization: evidence from cell line and patient-derived xenograft models D Wang, G Qian, H Zhang, KR Magliocca, S Nannapaneni, ARMR Amin, ... Clinical Cancer Research 23 (3), 677-686, 2017 | 68 | 2017 |
| Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection RS Prabhu, S Hanasoge, KR Magliocca, BJ Moeller, ZL Milas, WA Hall, ... Cancer 120 (10), 1499-1506, 2014 | 62 | 2014 |
| Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis LJ Joseph, M Goodman, K Higgins, R Pilai, SS Ramalingam, K Magliocca, ... Oral Oncology 51 (6), 586-592, 2015 | 61 | 2015 |
nabil sabaProfessor and Vice Chair, Lynne and Howard Halpern Chair in Head and Neck Cancer Research在 emory.edu 的电子邮件经过验证
